Ark Invest's ARK Next Generation Internet ETF (ARKW) bought about 18,783 Netflix shares, worth roughly $1.2 million, on Wednesday after the streamer posted a disappointing third-quarter report showing weak engagement and slowing growth; the stock slid 5% that day. Ark first invested in Netflix in 2016, exited in 2022, and reopened its position last October, attracted by the ad tier and push into live entertainment. The article cites weak engagement, with total viewing hours up just 2% in the first half, Netflix's U.S. audience share falling from 8.8% to 7.8% according to Nielsen, and a cut to 2026 advertising revenue guidance from $3 billion to $2.7 billion. The author expects weakness could persist in the near term, but sees a long-term recovery case given the new Chief Content Officer, with the stock trading at a price-to-earnings ratio around 21.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
NetflixETFCathie Woodadvertising
Open a keyword to see other news on the same topic.
Related news
- Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Ark Invest, which publishes Cathie Wood's ETF trades daily, added to existing positions in Netflix (NFLX), Oklo (OKLO) and Intuitive Surgical (ISRG) on Wednesday, and all three are down between 7% and 80% over the past year. Netflix hit a two-year low after guiding to an 11.5% revenue increase for the final quarter, its weakest showing in more than three years, though it has more than 300 million members and trades at 17 times next year's estimated earnings. Oklo has surrendered 86% of its value from its all-time high, with a $5.2 billion market cap and revenue not expected to top $10 million next year. Intuitive Surgical is down 7% over the past year and nearly a quarter in 2026, as analysts see revenue growth slowing to 13% next quarter.
- Cathie Wood Just Poured Millions Into 2 Nuclear Stocks -- and Neither Was NuScale Power
Ark Invest funds run by Cathie Wood bought shares of X-Energy and Oklo this week, though none of its ETFs hold NuScale Power. On October 22, ARK Innovation ETF (ARKK), ARK Autonomous Tech & Robotics ETF (ARKQ) and ARK Space & Defense Innovation ETF (ARKX) bought 292,022, 126,437 and 66,436 X-Energy shares, an estimated $5.1 million total at an assumed average price of $10.48. Purchases continued on Wednesday, adding about $2.2 million of X-Energy stock through ARKQ and ARKX. ARKQ also bought 150,998 Oklo shares on October 22, valued at about $4.1 million as the stock traded between $26.36 and $28.20. The article notes that neither company has started commercial SMR operations, so both carry higher risk, and cautions against blindly following other investors' buying activity.
- Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms
On Friday, Ark Invest led by Cathie Wood trimmed several technology holdings across its ARKK and ARKW funds, including Palantir (PLTR), Shopify (SHOP), Alphabet (GOOG) and Cloudflare (NET). ARKW also sold shares of Circle (CRCL), Roblox (RBLX), CrowdStrike (CRWD) and other names. In contrast, the ARKG fund bought biotechnology companies including Pacific Biosciences (PACB), Scribe Therapeutics (SCTX) and Freenome (FRNM), buying 169,498 FRNM shares and 68,266 PACB shares. PACB was also added to ARKK. ARKG closed up nearly 1% in the regular session and rose nearly 0.2% after hours, while retail sentiment on Stocktwits was neutral.
- Cathie Wood's Ark Invest Grew Its Portfolio to $15.4 Billion Last Quarter, With Tesla, AMD, and a New SpaceX Stake Making Up About 18% of ARKK Assets. Is Her Concentrated Bet Paying Off?
According to its latest 13F filing, Cathie Wood's Ark Invest had USD 15.4 billion in assets under management as of the second quarter. Its flagship Ark Innovation ETF (ARKK) is concentrated in a few names: as of Oct. 19, Tesla made up about 9.7%, SpaceX about 6.4% and AMD about 1.75% of fund assets, or roughly 18% combined. Since its October 2014 inception, ARKK has returned about 14.3% annualized, but after its 0.75% expense ratio it has not beaten the S&P 500, and its five-year annualized return is -4.06%. The article compares it with the Vanguard Information Technology ETF (VGT), which charges 0.09%, has averaged 20.9% annual returns over five years, and excludes Tesla and SpaceX under its benchmark's definition of technology.
- Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.
Ark Invest founder Cathie Wood holds $379.1 million of CRISPR Therapeutics shares and bought $1.1 million on Oct. 9 and $2.3 million on Oct. 12 through the ARK Genomic Revolution ETF, even though the stock is down more than 25% over the past year. CRISPR's only approved therapy, Casgevy, posted $76 million in Q2 revenue, up 151% year over year, but its $2.2 million list price and the 60% revenue share going to Vertex limit its economics. The company's net loss narrowed to $91.2 million from $208.5 million, and it holds $2.36 billion in cash. The article also points to CTX-310, which cut LDL cholesterol by 53% and triglycerides by 48% after 12 months in a phase 1a trial, and to a phase 2 readout for blood thinner CTX611 expected later this year.
- Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
Ark Investment Management, led by Cathie Wood, holds $220.4 million in Beam Therapeutics (BEAM) shares through its Ark ETFs, and recently bought another $2.8 million worth on Oct. 12 and 13 for the Ark Genomic Revolution (ARKG) fund. Beam develops gene-editing therapies using base editing, which changes single nucleotides without cutting both DNA strands, and its lead candidate, risto-cel, is in early trials for severe sickle cell disease. The company is far from profitable: first-half revenue was $32.2 million, up 50.5%, and loss per share was $2.09 versus $2.12 a year earlier, while $1.15 billion in cash is expected to fund operations through mid-2029. The stock is down more than 14% this year, and the article notes that the next 12 to 18 months will bring dense data readouts that could significantly lift the shares if positive.
Related markets
Latest news
- SpaceX Could Weather a Recession. But Its Stock Might Not. Here's Why.
SpaceX (SPCX) is well positioned in a downturn, with Starlink generating recurring subscription revenue and growing rapidly. In the third quarter, revenue rose 161% year over year to $14.6 billion and net income reached $4.4 billion. Connectivity revenue grew 69% to $5.2 billion and Starlink subscribers reached 13.6 million, but average monthly revenue per subscriber fell from $83 to $69. Capex was $19.6 billion in the quarter, including $16.4 billion on AI infrastructure, more than its connectivity revenue, and the company ended the quarter with $90 billion in cash and securities. The article warns the business could keep growing while the stock falls, given a price-to-sales ratio of 64.
- This Overlooked Pipeline Stock Could Be a Generational Wealth Builder for Patient Investors
Hess Midstream (HESM) has fallen about 20% over the past month after Chevron said it would sell its stake in the company. The drop followed an agreement to accept lower fees from Chevron in the Bakken Shale from 2027 through 2033, which led to lower 2026 EBITDA guidance and a tepid 2027 outlook. The article argues the decline may be too far, too fast, noting that integrated oil companies often divest midstream assets and that Chevron extended its use of Hess Midstream infrastructure to 2045. The transfer of Denver-Julesburg Basin energy storage assets also broadens the company's footprint. With shares yielding 10% and Chevron's stake transfer set to cut the share count by 40%, the author sees long-term positives and a possible near-term dividend increase.
- Audi defends plans for a $4 billion Georgia plant amid VW restructuring, tariffs
Audi CEO Gernot Dollner defended the carmaker's plan for a $4 billion plant in Georgia, its first in the U.S., which President Donald Trump announced at a Georgia rally on Saturday. Dollner said the move aims to grow sales and reduce exposure to U.S. tariffs, and that it does not take work away from Germany, which remains the backbone of the brand. The site followed more than 70 locations evaluated over many months and is expected to begin production of the Q7, Q8 and Q9 in the early 2030s, with capacity of up to 200,000 vehicles a year, roughly half to be exported. The announcement comes as parent Volkswagen plans to cut 50,000 jobs and close four German plants, including an Audi facility, between 2031 and 2034. U.S. tariffs cost Audi 1.2 billion euros ($1.4 billion) last year, and tariffs on German vehicles are now 15%, down from 25%.
- Wells Fargo, Cisco, Intuit Among 6 More Companies Objecting to Tokenized Stocks
Six more companies, including Wells Fargo, Cisco, Marvell, Arm Holdings, Moderna and Intuit, have objected to trading their shares on the OKXICE TSV tokenized stock venue, bringing the total to 22, up from nine on October 15. The notices do not give reasons or explain what an objection does. The venue, a 50-50 joint venture of Intercontinental Exchange and OKX's U.S. holding company, plans 24/7 trading of tokenized U.S. stocks on OKX's XLayer blockchain, paired with stablecoins like USDC, under the SEC's innovation exemption. Its updated notice also flags risks, including no circuit breakers beyond trading halts, no policies on maximal extractable value, and smart contract upgrades without advance notice to users.
- Wells Fargo, Cisco, Intuit Among 6 More Companies Objecting to Tokenized Stocks
Six more companies, including Wells Fargo, Cisco, Marvell, Arm, Moderna and Intuit, have objected to trading their shares on OKXICE TSV, according to an Oct. 23 notice, bringing the total to 22, up from 16 on Oct. 19 and nine on Oct. 15. The notices do not explain the companies' reasons or the effect of an objection. The venue, a 50-50 joint venture of Intercontinental Exchange and OKX's U.S. holding company, plans to let approved users trade tokenized U.S. stocks 24/7, paired with stablecoins such as USDC, under the SEC's innovation exemption. The latest notice also flags risks, including no circuit breakers beyond trading halts, no policies on maximal extractable value, unsettled questions for broker-dealers on trade reporting and best execution, and smart contracts that can be upgraded without advance notice. Nasdaq has said it will opt its shares out of the exemption.
- Does enough capital exist to finance everyone's ambitious AI spending plans?
Meta said recent capital raises by peers such as Alphabet and SpaceX, plus expected fundraising by Anthropic and OpenAI, have created an 'increasingly challenging' fundraising environment, raising doubts over whether enough capital exists for AI spending. Meta's revenue rose 26% to $64.6 billion, though free cash flow was negative $2.1 billion, and it raised the low end of its 2026 capex forecast to $135 billion to $145 billion. Broadcom's Hock Tan and BlackRock's Larry Fink voiced similar concerns as AI-linked stocks led a Nasdaq selloff of 2.6%, with Nvidia down 4.4% and CoreWeave down 10.1%. Yardeni Research said money moved to other parts of the market, as the equal-weighted S&P 500 rose 0.7% while the cap-weighted version fell 1.2%, and Treasury yields dropped. Amazon, Alphabet, Meta, Microsoft and Oracle are projected to spend almost $780 billion in 2026 and more than $1 trillion a year from 2027 through 2030.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.